glp-1 fast food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels GLP-1 Restaurant Guide: What to

Sharing this context with your provider may help justify why a particular compounded GLP-1 option, dosing strategy, or combination therapy is most appropriate for your situation and metabolic profile

Pfizer/Metsera is testing MET-097i at both once-weekly and one-monthly regimens in phase 2 trials

Bibliografa: 1 Stephens FB, Constantin-Teodosiu D, Greenhaff PL

In a review of the large studies, melanoma of the oral cavity is reported to account for 0.2-8% of melanomas and approximately 1.6% of all malignancies of the head and neck

This reporting is essential for building the safety evidence base that regulators such as the MHRA rely upon when assessing new medicines